Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
STROKE | Editor's Picks | March 2020
03/10/2020 | Stroke Editor's Picks for March 2020
Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation
03/09/2020 | Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with high morbidity, mortality and healthcare usage.
Exercise-Related Acute Cardiovascular Events & Potential Deleterious Adaptations
02/26/2020 | The benefits of regular moderate-to-vigorous physical activity (PA), and the associated improvements in cardiorespiratory fitness (CRF), far outweigh the risks for most individuals.
Circulation: Cardiovascular Imaging | Twitter Journal Club | Feb 28, 12-1 pm EST
02/24/2020 | Circulation: Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies
STROKE | Progress and Innovation Award 2019
02/12/2020 | Stroke 2019 Innovation and Progress Award Winners--first: Ma and Wang, Second: Yip, Third: Schlunk
Public Comment: 2020 ACC/AHA Performance Measures for Adult with Heart Failure
02/07/2020 | We would like to invite you to participate in the review of the draft version of the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults with Heart Failure.
JAHA | Featured Articles | February 4, 2020
02/07/2020 | New featured articles from JAHA for February 4, 2020
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.
JAHA | Featured Articles | January 21, 2020
01/27/2020 | New featured articles from JAHA for January 21, 2020